Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1997-1-21
|
pubmed:abstractText |
We chose to evaluate whether or not a state of biochemical hypercoagulability was present in 74 individuals (69 heterozygotes and 5 homozygotes) resistant to activated protein C (APC) due to the Arg506 --> Gln mutation in the factor V gene. To this end, plasma levels of two markers of thrombin formation, prothrombin fragment 1 + 2 (F1+2) and thrombin-antithrombin complexes (TAT) were measured. High levels of F1+2 and TAT were found in 32% and 23% of APC-resistant individuals vs 4% in controls. The levels of these markers tended to be particularly elevated in three homozygous subjects. A significant positive correlation between F1+2 and TAT was present in APC-resistant individuals. No relationship between marker values and the previous occurrence of thrombotic episodes was found. Therefore, by measuring F1+2 and TAT a state of biochemical hypercoagulability has been identified in about one-third of APC-resistant individuals. This frequency is similar to that previously observed in comparable individuals with inherited deficiencies of protein C and protein S, which are usually associated with a stronger thrombotic tendency than APC-resistant individuals.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anticoagulants,
http://linkedlifedata.com/resource/pubmed/chemical/Factor V,
http://linkedlifedata.com/resource/pubmed/chemical/Protein C,
http://linkedlifedata.com/resource/pubmed/chemical/Prothrombin,
http://linkedlifedata.com/resource/pubmed/chemical/Thrombin
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0340-6245
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
75
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
703-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8725708-Adolescent,
pubmed-meshheading:8725708-Adult,
pubmed-meshheading:8725708-Aged,
pubmed-meshheading:8725708-Anticoagulants,
pubmed-meshheading:8725708-Child,
pubmed-meshheading:8725708-Drug Resistance,
pubmed-meshheading:8725708-Factor V,
pubmed-meshheading:8725708-Heterozygote,
pubmed-meshheading:8725708-Homozygote,
pubmed-meshheading:8725708-Humans,
pubmed-meshheading:8725708-Middle Aged,
pubmed-meshheading:8725708-Protein C,
pubmed-meshheading:8725708-Prothrombin,
pubmed-meshheading:8725708-Thrombin,
pubmed-meshheading:8725708-Thrombosis
|
pubmed:year |
1996
|
pubmed:articleTitle |
Heightened thrombin generation in individuals with resistance to activated protein C.
|
pubmed:affiliation |
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital, Italy.
|
pubmed:publicationType |
Journal Article
|